Free Trial

Hemab Therapeutics (COAG) Insider Trading & Ownership

Hemab Therapeutics logo
$27.84 +1.95 (+7.53%)
As of 04:00 PM Eastern

Hemab Therapeutics (NASDAQ:COAG) Insider Buying and Selling Activity

Number Of
Insiders Buying
(Last 12 Months)
9
Amount Of
Insider Buying
(Last 12 Months)
$53.77M
Number Of
Insiders Selling
(Last 12 Months)
0
Get COAG Insider Trade Alerts

Want to know when executives and insiders are buying or selling Hemab Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

COAG Insider Buying and Selling by Quarter

Hemab Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/20/2026
Ra Capital Management, L.P.
Major Shareholder
Buy996$24.94$24,840.24  
5/19/2026
Ra Capital Management, L.P.
Major Shareholder
Buy3,802$24.97$94,935.94  
5/12/2026
Ra Capital Management, L.P.
Major Shareholder
Buy6,387$24.90$159,036.30  
5/11/2026
Ra Capital Management, L.P.
Major Shareholder
Buy39,869$24.81$989,149.89  
5/8/2026
Ra Capital Management, L.P.
Major Shareholder
Buy1,483$24.98$37,045.34  
5/7/2026
Ra Capital Management, L.P.
Major Shareholder
Buy9,906$24.46$242,300.76  
5/6/2026
Ra Capital Management, L.P.
Director
Buy68,018$24.60$1,673,242.80  
5/5/2026
Ra Capital Management, L.P.
Director
Buy97,411$24.63$2,399,232.93  
5/4/2026
Ra Capital Management, L.P.
Director
Buy2,675,000$18.00$48,150,000.00  
(Data available from 1/1/2013 forward)

COAG Insider Trading Activity - Frequently Asked Questions

The list of insiders at Hemab Therapeutics includes Ra Capital Management, L.P.. Learn more on insiders at COAG.

The following insider purchased COAG shares in the last 24 months: Ra Capital Management, L.P. ($53,769,784.20).

Insiders have purchased a total of 2,902,872 COAG shares in the last 24 months for a total of $53,769,784.20 bought.



This page (NASDAQ:COAG) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners